Is Mylan Allergic to Good PR?
By Samuel Taube The last time we looked at Mylan (Nasdaq: MYL) was in a Stock Grader profile more than six months ago. That was right in the middle of the company’s first EpiPen scandal, when Mylan came under heavy political fire for more than doubling the injector’s price. Despite all the outrage around the […]
Is Mylan Allergic to Good PR? Read More »